Quick search
In Drug search, users can search candidate drugs/compounds that associate with CST.
Result
This table shows chemicals/drugs, their mechanism of action(MOA) and association with CST.
Chemical | Cancer | MOA | Association | ||
---|---|---|---|---|---|
prima-1-met | STAD | thioredoxin inhibitor | negatively | ||
PRL-3-inhibitor-I | STAD | Tyrosine phosphatase inhibitor | negatively | ||
probucol | STAD | Atherogenesis inhibitor | negatively | ||
prostaglandin | STAD | Prostanoid receptor antagonist | negatively | ||
PT-630 | STAD | Dipeptidyl peptidase inhibitor | negatively | ||
PTB1 | STAD | AMPK activator | negatively | ||
QW-BI-011 | STAD | Histone lysine methyltransferase inhibitor | negatively | ||
rilmenidine | STAD | Imidazoline receptor agonist | negatively | ||
ruxolitinib | STAD | JAK inhibitor | negatively | ||
RWJ-21757 | STAD | TLR agonist | negatively | ||
SB-216763 | STAD | Glycogen synthase kinase inhibitor | negatively | ||
SB-525334 | STAD | TGF beta receptor inhibitor | negatively | ||
scoulerine | STAD | Adrenergic receptor antagonist | negatively | ||
securinine | STAD | GABA receptor antagonist | negatively | ||
sitagliptin | STAD | Dipeptidyl peptidase inhibitor | negatively | ||
SJ-172550 | STAD | MDM inhibitor | negatively | ||
SR-142948 | STAD | Neurotensin receptor antagonist | negatively | ||
sulforaphane | STAD | Antineoplastic | negatively | ||
sunitinib | STAD | FLT3 inhibitor | negatively | ||
tadalafil | STAD | Phosphodiesterase inhibitor | negatively | ||